# A Study Evaluating AHB-137 in Healthy Participants and Participants with Chronic Hepatitis B

> **NCT05717686** · PHASE1 · COMPLETED · sponsor: **AusperBio Therapeutics Inc.** · enrollment: 64 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** AHB-137 injection
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05717686
- **Lead sponsor:** AusperBio Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-28
- **Primary completion:** 2025-01-07
- **Final completion:** 2025-01-07
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2025-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05717686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05717686, "A Study Evaluating AHB-137 in Healthy Participants and Participants with Chronic Hepatitis B". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05717686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*